Annalice Gandini, Research fellow at Centre de Recherche des Cordeliers and Hospital Georges Pompidou, shared a post on LinkedIn:
“It was an honor to present as rapid oral at the ESMO Gastrointestinal Cancers Annual Congress the first results of the AGEO-NEO-MSI study, evaluating neoadjuvant immunotherapy in 316 dMMR/MSI colorectal cancer patients treated in more than 30 international centers.
Thanks to the patients who participated, the colleagues who contributed to this work and the scientific committee for having selected our abstract!”
Other articles about ESMO GI 2026 on OncoDaily.